Global Blood Stream Infection Testing Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

Summary

BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.  
North America accounts for the largest market share of the global market owing to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities. It is followed by Europe in terms of market share. Asia Pacific is anticipated to hold the third largest market share owing to large population pool and poor hygienic sense. Latin America and Middle East & Africa are the silent contributors of the market.
In 2018, the global Blood Stream Infection Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2019 and 2025.

This report studies the Blood Stream Infection Testing market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX

Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing

Market segment by Application, the market can be split into
Hospitals
Independent Diagnostic Centers
Others

The study objectives of this report are:
To study and forecast the market size of Blood Stream Infection Testing in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Blood Stream Infection Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Blood Stream Infection Testing market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.